NCT02925312View on ClinicalTrials.gov

MedStar Health Type 2 Diabetes Pathway to Control

NACompletedINTERVENTIONAL
Enrollment

419

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

December 31, 2016

Conditions
Type 2 Diabetes MellitusHyperglycemia
Interventions
OTHER

Diabetes Pathway

Medication algorithm, survival skills education, enhanced patient-provider communication facilitated by near, real-time blood glucose monitoring

Trial Locations (1)

20010

MedStar Washington Hospital Center, Washington D.C.

Sponsors
All Listed Sponsors
lead

Medstar Health Research Institute

OTHER